Association between 25(OH)D level, ultraviolet exposure, geographical location, and inflammatory bowel disease activity: A systematic review and meta-analysis

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Lu, Chao ^a   Yang, Jun ^a   Yu, Weilai ^a   Li, Dejian ^a   Xiang, Zun ^a   Lin, Yiming ^a   Yu, Chaohui ^a   Green, John ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIFEDIOL;

ARTICLE; CASE CONTROL STUDY; CHROMATOGRAPHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFLAMMATORY BOWEL DISEASE; LATITUDE; MORBIDITY; PATHOGENESIS; RADIATION EXPOSURE; RADIOIMMUNOASSAY; RISK FACTOR; SUN EXPOSURE; SYSTEMATIC REVIEW; ULTRAVIOLET RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALYSIS; GEOGRAPHY; INFLAMMATORY BOWEL DISEASES; META ANALYSIS; METABOLISM;

CALCIFEDIOL; GEOGRAPHY; HUMANS; INFLAMMATORY BOWEL DISEASES; RADIATION EXPOSURE; ULTRAVIOLET RAYS;

EID: 84940521747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132036     Document Type: Article

References (67)

1. Abraham C, Cho JH. Inflammatory bowel disease. The New England journal of medicine. 2009; 361 (21):2066-78. Epub 2009/11/20. doi: 10.1056/NEJMra0804647 PMID: 19923578; PubMed Central PMCID: PMCPMC3491806.
2. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126(6):1504-17. Epub 2004/05/29. PMID: 15168363.
3. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411(6837):603-6. Epub 2001/06/01. doi: 10.1038/35079114 PMID: 11385577.
4. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (New York, NY). 2006; 314 (5804):1461-3. Epub 2006/10/28. doi: 10.1126/science.1135245 PMID: 17068223.
5. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nature reviews Immunology. 2003; 3(7):521-33. Epub 2003/07/24. doi: 10.1038/nri1132 PMID: 12876555.
6. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011; 140(6):1785-94. Epub 2011/05/03. doi: 10.1053/j.gastro.2011.01.055 PMID: 21530745.
7. Cantorna MT, Mahon BD. Mounting evidence for vitamin Das an environmental factor affecting autoimmune disease prevalence. Experimental biology and medicine (Maywood, NJ). 2004; 229(11):1136-42. Epub 2004/11/27. PMID: 15564440.
8. Peterlik M, Cross HS. Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. European journal of clinical nutrition. 2009; 63(12):1377-86. Epub 2009/09/03. doi: 10.1038/ejcn.2009.105 PMID: 19724293.
9. Hughes MR, Malloy PJ, Kieback DG, Kesterson RA, Pike JW, Feldman D, et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science (New York, NY). 1988; 242(4886):1702-5. Epub 1988/12/23. PMID: 2849209.
10. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrine reviews. 2008; 29(6):726-76. Epub 2008/08/13. doi: 10.1210/er.2008-0004 PMID: 18694980; PubMed Central PMCID: PMCPMC2583388.
11. Gascon-Barre M, Demers C, Mirshahi A, Neron S, Zalzal S, Nanci A. The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology (Baltimore, Md). 2003; 37(5):1034-42. Epub 2003/04/30. doi: 10.1053/jhep.2003.50176 PMID: 12717384.
12. Mouli VP, Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Alimentary pharmacology & therapeutics. 2014; 39(2):125-36. Epub 2013/11/19. doi: 10.1111/apt.12553 PMID: 24236989; PubMed Central PMCID: PMCPMC3872479.
13. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Journal of clinical epidemiology. 2008; 61(4):344-9. Epub 2008/03/04. doi: 10.1016/j.jclinepi.2007.11.008 PMID: 18313558.
14. Deeks JJ, Dinnes J, DAmico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. Health technology assessment (Winchester, England). 2003; 7(27):iii-x, 1-173. Epub 2003/09/23. PMID: 14499048.
15. Viswanathan M, Ansari MT, Berkman ND, Chang S, Hartling L, McPheeters M, et al. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville MD2008.
16. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2011; 96(7):1911-30. Epub 2011/06/08. doi: 10.1210/jc.2011-0385 PMID: 21646368.
17. Garg M, Rosella O, Lubel JS, Gibson PR. Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflammatory bowel diseases. 2013; 19(12):2634-43. Epub 2013/10/10. doi: 10.1097/01.MIB.0000436957.77533.b2 PMID: 24105392.
18. Middleton JP, Bhagavathula AP, Gaye B, Alvarez JA, Huang CS, Sauer CG, et al. Vitamin D status and bone mineral density in African American children with Crohn disease. Journal of pediatric gastroenterology and nutrition. 2013; 57(5):587-93. Epub 2013/06/14. doi: 10.1097/MPG.0b013e31829e0b89 PMID: 23760229; PubMed Central PMCID: PMCPMC3845217.
19. Dunn OJ, Virginia A. Clark. Basic statistics: a primer for the biomedical sciences. John Wiley & Sons. 2009; Edition 4.
20. El-Matary W, Sikora S, Spady D. Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Digestive diseases and sciences. 2011; 56(3):825-9. Epub 2010/08/21. doi: 10.1007/s10620-010-1380-5 PMID: 20725784.
21. Veit LE, Maranda L, Fong J, Nwosu BU. The vitamin D status in inflammatory bowel disease. PloS one. 2014; 9(7):e101583. Epub 2014/07/06. doi: 10.1371/journal.pone.0101583 PMID: 24992465; PubMed Central PMCID: PMCPMC4081562.
22. de Bruyn JR, van Heeckeren R, Ponsioen CY, vanden Brink GR, Lowenberg M, Bredenoord AJ, et al. Vitamin D deficiency in Crohn's disease and healthy controls: a prospective case-control study in the Netherlands. Journal of Crohn's & colitis. 2014; 8(10):1267-73. Epub 2014/03/29. doi: 10.1016/j.crohns.2014.03.004 PMID: 24666975.
23. Dumitrescu G, Mihai C, Dranga M, Prelipcean CC. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania. World journal of gastroenterology: WJG. 2014; 20(9):2392-6. Epub 2014/03/08. doi: 10.3748/wjg.v20.i9.2392 PMID: 24605037; PubMed Central PMCID: PMCPMC3942843.
24. Grunbaum A, Holcroft C, Heilpern D, Gladman S, Burstein B, Menard M, et al. Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families. Nutrition journal. 2013; 12 (1):145. Epub 2013/11/12. doi: 10.1186/1475-2891-12-145 PMID: 24206944; PubMed Central PMCID: PMCPMC3828424.
25. Jorgensen SP, Hvas CL, Agnholt J, Christensen LA, Heickendorff L, Dahlerup JF. Active Crohn's disease is associated with low vitamin D levels. Journal of Crohn's & colitis. 2013; 7(10):e407-13. Epub 2013/02/14. doi: 10.1016/j.crohns.2013.01.012 PMID: 23403039.
26. Joseph AJ, George B, Pulimood AB, Seshadri MS, Chacko A. 25 (OH) vitamin D level in Crohn's disease: association with sun exposure & disease activity. The Indian journal of medical research. 2009; 130(2):133-7. Epub 2009/10/03. PMID: 19797809.
27. Souza HN, Lora FL, Kulak CA, Manas NC, Amarante HM, Borba VZ. [Low levels of 25-hydroxyvitamin D (25OHD) in patients with inflammatory bowel disease and its correlation with bone mineral density]. Arquivos brasileirosdeendocrinologiae metabologia. 2008; 52(4):684-91. Epub 2008/07/08. PMID: 18604382.
28. Suibhne TN, Cox G, Healy M, O'Morain C, O'Sullivan M. Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. Journal of Crohn's & colitis. 2012; 6 (2):182-8. Epub 2012/02/14. doi: 10.1016/j.crohns.2011.08.002 PMID: 22325172.
29. Tajika M, Matsuura A, Nakamura T, Suzuki T, Sawaki A, Kato T, et al. Risk factors for vitamin D deficiency in patients with Crohn's disease. Journal of gastroenterology. 2004; 39(6):527-33. Epub 2004/07/06. doi: 10.1007/s00535-003-1338-x PMID: 15235869.
30. Tan B, Li P, Lv H, Li Y, Wang O, Xing XP, et al. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease. Journal of digestive diseases. 2014; 15(3):116-23. Epub 2013/12/21. doi: 10.1111/1751-2980.12118 PMID: 24354597.
31. McCarthy D, Duggan P, O'Brien M, Kiely M, McCarthy J, Shanahan F, et al. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Alimentary pharmacology & therapeutics. 2005; 21(9):1073-83. Epub 2005/04/28. doi: 10.1111/j.1365-2036.2005.02446.x PMID: 15854168.
32. Prosnitz AR, Leonard MB, Shults J, Zemel BS, Hollis BW, Denson LA, et al. Changes in vitamin D and parathyroid hormone metabolism in incident pediatric Crohn's disease. Inflammatory bowel diseases. 2013; 19(1):45-53. Epub 2012/04/11. doi: 10.1002/ibd.22969 PMID: 22488969.
33. Fu YT, Chatur N, Cheong-Lee C, Salh B. Hypovitaminosis D in adults with inflammatory bowel disease: potential role of ethnicity. Digestive diseases and sciences. 2012; 57(8):2144-8. Epub 2012/03/28. doi: 10.1007/s10620-012-2130-7 PMID: 22451117.
34. Ham M, Longhi MS, Lahiff C, Cheifetz A, Robson S, Moss AC. Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment. Inflammatory bowel diseases. 2014; 20 (5):856-60. Epub 2014/04/01. doi: 10.1097/mib.0000000000000016 PMID: 24681654; PubMed Central PMCID: PMCPMC4077052.
35. Hassan V, Hassan S, Seyed-Javad P, Ahmad K, Asieh H, Maryam S, et al. Association between Serum 25 (OH) Vitamin D Concentrations and Inflammatory Bowel Diseases (IBDs) Activity. The Medical journal of Malaysia. 2013; 68(1):34-8. Epub 2013/03/08. PMID: 23466764.
36. Levin AD, Wadhera V, Leach ST, Woodhead HJ, Lemberg DA, Mendoza-Cruz AC, et al. Vitamin D deficiency in children with inflammatory bowel disease. Digestive diseases and sciences. 2011; 56(3):830-6. Epub 2011/01/12. doi: 10.1007/s10620-010-1544-3 PMID: 21222159.
37. Sentongo TA, Semaeo EJ, Stettler N, Piccoli DA, Stallings VA, Zemel BS. Vitamin D status in children, adolescents, and young adults with Crohn disease. The American journal of clinical nutrition. 2002; 76 (5):1077-81. Epub 2002/10/26. PMID: 12399281.
38. Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN Journal of parenteral and enteral nutrition. 2011; 35(3):308-16. Epub 2011/04/30. doi: 10.1177/0148607110381267 PMID: 21527593.
39. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70(3):439-44. Epub 1976/03/11. PMID: 1248701.
40. Harvey RF, Bradshaw MJ. Measuring Crohn's disease activity. Lancet. 1980; 1(8178):1134-5. Epub 1980/05/24. PMID: 6103463.
41. Economou M, Pappas G. New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations. Inflammatory bowel diseases. 2008; 14(5):709-20. Epub 2007/12/21. doi: 10.1002/ibd.20352 PMID: 18095316.
42. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. The American journal of clinical nutrition. 1995; 61(3 Suppl):638S-45S. Epub 1995/03/01. PMID: 7879731.
43. Jantchou P, Clavel-Chapelon F, Racine A, Kvaskoff M, Carbonnel F, Boutron-Ruault MC. High residential sun exposure is associated with a low risk of incident Crohn's disease in the prospective E3N cohort. Inflammatory bowel diseases. 2014; 20(1):75-81. Epub 2013/11/20. doi: 10.1097/01.MIB.0000436275.12131.4f PMID: 24247650.
44. Limketkai BN, Bayless TM, Brant SR, Hutfless SM. Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation. Alimentary pharmacology & therapeutics. 2014; 40(5):508-17. Epub 2014/06/20. doi: 10.1111/apt.12845 PMID: 24943863.
45. Nerich V, Jantchou P, Boutron-Ruault MC, Monnet E, Weill A, Vanbockstael V, et al. Low exposure to sunlight is a risk factor for Crohn's disease. Alimentary pharmacology & therapeutics. 2011; 33(8):940-5. Epub 2011/02/22. doi: 10.1111/j.1365-2036.2011.04601.x PMID: 21332762.
46. Khalili H, Huang ES, Ananthakrishnan AN, Higuchi L, Richter JM, Fuchs CS, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut. 2012; 61(12):1686-92. Epub 2012/01/14. doi: 10.1136/gutjnl-2011-301574 PMID: 22241842; PubMed Central PMCID: PMCPMC3418414.
47. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996; 39(5):690-7. Epub 1996/11/01. PMID: 9014768; PubMed Central PMCID: PMCPMC1383393.
48. Yang L, Weaver V, Smith JP, Bingaman S, Hartman TJ, Cantorna MT. Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients. Clinical and translational gastroenterology. 2013; 4:e33. Epub 2013/04/19. doi: 10.1038/ctg.2013.1 PMID: 23594800; PubMed Central PMCID: PMCPMC3636524.
49. Bendix-Struve M, Bartels LE, Agnholt J, Dige A, Jorgensen SP, Dahlerup JF. Vitamin D3 treatment of Crohn's disease patients increases stimulated T cell IL-6 production and proliferation. Alimentary pharmacology & therapeutics. 2010; 32(11-12):1364-72. Epub 2010/11/06. doi: 10.1111/j.1365-2036.2010.04463.x PMID: 21050239.
50. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annual review of medicine. 2000; 51:289-98. Epub 2000/04/25. doi: 10.1146/annurev.med.51.1.289 PMID: 10774465.
51. Hewison M. Vitamin D and immune function: an overview. The Proceedings of the Nutrition Society. 2012; 71(1):50-61. Epub 2011/08/19. doi: 10.1017/s0029665111001650 PMID: 21849106.
52. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. Journal of immunology (Baltimore, Md: 1950). 2001; 167(9):4974-80. Epub 2001/10/24. PMID: 11673504.
53. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nature reviews Immunology. 2008; 8(9):685-98. Epub 2009/01/28. doi: 10.1038/nri2378 PMID: 19172691; PubMed Central PMCID: PMCPMC2906676.
54. Muller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, Bendtzen K. 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine. 1992; 4 (6):506-12. Epub 1992/11/01. PMID: 1337987.
55. Chen Y, Liu W, Sun T, Huang Y, Wang Y, Deb DK, et al. 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages. Journal of immunology (Baltimore, Md: 1950). 2013; 190(7):3687-95. Epub 2013/02/26. doi: 10.4049/jimmunol.1203273 PMID: 23436936; PubMed Central PMCID: PMCPMC3608760.
56. Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, Tavera-Mendoza LE, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. The Journal of biological chemistry. 2010; 285(4):2227-31. Epub 2009/12/02. doi: 10.1074/jbc.C109.071225 PMID: 19948723; PubMed Central PMCID: PMCPMC2807280.
57. Wu S, Sun J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discovery medicine. 2011; 11(59):325-35. Epub 2011/04/29. PMID: 21524386; PubMed Central PMCID: PMCPMC3285235.
58. Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC immunology. 2007; 8:5. Epub 2007/04/03. doi: 10.1186/1471-2172-8-5 PMID: 17397543; PubMed Central PMCID: PMCPMC1852118.
59. Wu S, Liao AP, Xia Y, Li YC, Li JD, Sartor RB, et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. The American journal of pathology. 2010; 177(2):686-97. Epub 2010/06/23. doi: 10.2353/ajpath.2010.090998 PMID: 20566739; PubMed Central PMCID: PMCPMC2913341.
60. Froicu M, Zhu Y, Cantorna MT. Vitamin D receptor is required to control gastrointestinal immunity in IL10 knockout mice. Immunology. 2006; 117(3):310-8. Epub 2006/02/16. doi: 10.1111/j.1365-2567.2005.02290.x PMID: 16476050; PubMed Central PMCID: PMCPMC1782241.
61. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. The Journal of pharmacology and experimental therapeutics. 2008; 324(1):23-33. Epub 2007/10/04. doi: 10.1124/jpet.107.127209 PMID: 17911375.
62. Ananthakrishnan AN, Cagan A, Gainer VS, Cheng SC, Cai T, Szolovits P, et al. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Alimentary pharmacology & therapeutics. 2014; 39(10):1136-42. Epub 2014/03/20. doi: 10.1111/apt.12706 PMID: 24641590; PubMed Central PMCID: PMCPMC4187206.
63. Kini GP, Young B, Herbison P, Schultz M. Does seasonal level of serum 25-OH vitamin D correlate with the activity of Crohn's disease? The New Zealand medical journal. 2014; 127(1394):51-9. Epub 2014/06/16. PMID: 24929571.
64. Aratari A, Papi C, Galletti B, Angelucci E, Viscido A, D'Ovidio V, et al. Seasonal variations in onset of symptoms in Crohn's disease. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2006; 38(5):319-23. Epub 2005/11/18. doi: 10.1016/j.dld.2005.10.002 PMID: 16289974.
65. Koido S, Ohkusa T, Saito H, Yokoyama T, Shibuya T, Sakamoto N, et al. Seasonal variations in the onset of ulcerative colitis in Japan. World journal of gastroenterology: WJG. 2013; 19(47):9063-8. Epub 2014/01/01. doi: 10.3748/wjg.v19.i47.9063 PMID: 24379632; PubMed Central PMCID: PMCPMC3870560.
66. Xue LN, Xu KQ, Zhang W, Wang Q, Wu J, Wang XY. Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis. Inflammatory bowel diseases. 2013; 19(1):54-60. Epub 2012/04/03. doi: 10.1002/ibd.22966 PMID: 22467262.
67. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, et al. IOM committee members respond to Endocrine Society vitamin D guideline. The Journal of clinical endocrinology and metabolism. 2012; 97(4):1146-52. Epub 2012/03/24. doi: 10.1210/jc.2011-2218 PMID: 22442278.